Burke Steven Keith
Officer at AKBA
- Sold, on record
- $461k
- Dollars the filings state
- Form 4 sales
- 15
- Latest Feb 2, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AKBAAkebia Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice AKBANoticeFeb 29, 2024 2024
Filed to sell 7,169 shares ($11k)
Burke Steven Keith, Officer
No 10b5-1 plan0.5x usual sizeFiling
- 2 Form 4 sale AKBANo planFeb 29, 2024 same day
Sold 7,169 shares at $1.58 ($11k)
Burke Steven Keith, SVP, Chief Medical Officer
No 10b5-1 planSold 1% of holdings ($1.1M position)695,840 shares left0.6x usual sizeFollows a Form 144Filing
- 3 Form 144 notice AKBANoticeFeb 3, 2025 +340 days
Filed to sell 50,506 shares ($106k)
Burke Steven Keith, Officer
No 10b5-1 plan3.6x usual sizeFiling
- 4 Form 4 sale AKBAUnusualFeb 3, 2025 same day
Sold 50,506 shares at $2.10 ($106k)
Burke Steven Keith, SVP, Chief Medical Officer
10b5-1 planSold 5.8% of holdings ($1.8M position)816,234 shares left3.6x usual sizeFollows a Form 144Filing
- 5 Form 144 notice AKBANoticeMar 3, 2025 +28 days
Filed to sell 7,144 shares ($13k)
Burke Steven Keith, Officer
No 10b5-1 plan0.3x usual sizeFiling
- 6 Form 4 sale AKBARoutineMar 3, 2025 same day
Sold 7,144 shares at $1.83 ($13k)
Burke Steven Keith, SVP, Chief Medical Officer
10b5-1 planSold 0.9% of holdings ($1.5M position)809,090 shares left0.3x usual sizeFollows a Form 144Filing
- 7 Form 144 notice AKBANoticeFeb 2, 2026 +336 days
Filed to sell 67,658 shares ($94k)
Burke Steven Keith, Officer
10b5-1 plan8.7x usual sizeFiling
- 8 Form 4 sale AKBAUnusualFeb 2, 2026 same day
Sold 67,658 shares at $1.39 ($94k)
Burke Steven Keith, SVP, Chief Medical Officer
10b5-1 planSold 6.7% of holdings ($1.4M position)948,432 shares left8.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (22)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 4, 2026 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 67,658 | $94k | 6.7% | Unusual | SEC |
| Feb 2, 2026 | Feb 2, 2026 | AKBA | Officer | Form 144 notice | 67,658 | $94k | Notice | SEC | |
| Mar 3, 2025 | Mar 4, 2025 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 7,144 | $13k | 0.9% | Routine | SEC |
| Mar 3, 2025 | Mar 3, 2025 | AKBA | Officer | Form 144 notice | 7,144 | $13k | Notice | SEC | |
| Feb 3, 2025 | Feb 4, 2025 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 50,506 | $106k | 5.8% | Unusual | SEC |
| Feb 3, 2025 | Feb 3, 2025 | AKBA | Officer | Form 144 notice | 50,506 | $106k | Notice | SEC | |
| Feb 29, 2024 | Mar 1, 2024 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 7,169 | $11k | 1.0% | No plan | SEC |
| Feb 29, 2024 | Feb 29, 2024 | AKBA | Officer | Form 144 notice | 7,169 | $11k | Notice | SEC | |
| Feb 27, 2024 | Feb 29, 2024 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 8,367 | $13k | 1.2% | Routine | SEC |
| Feb 27, 2024 | Feb 27, 2024 | AKBA | Officer | Form 144 notice | 8,367 | $13k | Notice | SEC | |
| Feb 1, 2024 | Feb 2, 2024 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 24,311 | $41k | 3.3% | No plan | SEC |
| Feb 1, 2024 | Feb 1, 2024 | AKBA | Officer | Form 144 notice | 24,311 | $41k | Notice | SEC | |
| Aug 25, 2023 | May 9, 2024 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 27,000 | $31k | 3.9% | No plan | SEC |
| May 16, 2023 | May 18, 2023 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 63,567 | $68k | 10.7% | Unusual | SEC |
| May 16, 2023 | May 16, 2023 | AKBA | Officer | Form 144 notice | 63,567 | $68k | Notice | SEC | |
| Mar 1, 2023 | Mar 3, 2023 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 14,123 | $12k | 2.3% | Unusual | SEC |
| Feb 27, 2023 | Mar 1, 2023 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 7,539 | $6k | 1.2% | Unusual | SEC |
| Aug 31, 2022 | Sep 1, 2022 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 1,147 | $413 | 0.3% | Plan not stated | SEC |
| Mar 1, 2022 | Mar 2, 2022 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 15,056 | $33k | 6.5% | Unusual | SEC |
| Aug 31, 2021 | Sep 2, 2021 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 1,042 | $3k | 0.6% | Plan not stated | SEC |
| Apr 1, 2021 | Apr 1, 2021 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 1,081 | $4k | 0.6% | Plan not stated | SEC |
| Mar 1, 2021 | Mar 2, 2021 | AKBA | SVP, Chief Medical Officer | Form 4 sale | 7,558 | $26k | 4.5% | Plan not stated | SEC |